REVIEW RSS FEED
PHARMA CEOS MAKE HUGE SALARIES
Unsilent Generation - One aspect of the health care reform battle which gets little attention is the cushy environment of the drug company executive. Fiercepharma blog, which tracks the industry not long ago ran a listing of all the dough these CEOs make.. . . Figures are for 2008.
1. Bill Weldon - Johnson & Johnson - $29.4M
2. Miles White - Abbott Laboratories - $28.3M
3. Bernard Poussot - Wyeth - $25M
4. Jim Cornelius - Bristol-Myers Squibb - $25M
5. Richard Clark - Merck - $19.9M
6. Robert Parkinson - Baxter International - $16M
7. David Vasella - Novartis - $15.1M
8. Jeffrey Kindler - Pfizer - $14.8M
9. Frank Baldino - Cephalon - $14.5M
10. John Lechleiter - Eli Lilly - $13M
1. Bill Weldon - Johnson & Johnson - $29.4M
2. Miles White - Abbott Laboratories - $28.3M
3. Bernard Poussot - Wyeth - $25M
4. Jim Cornelius - Bristol-Myers Squibb - $25M
5. Richard Clark - Merck - $19.9M
6. Robert Parkinson - Baxter International - $16M
7. David Vasella - Novartis - $15.1M
8. Jeffrey Kindler - Pfizer - $14.8M
9. Frank Baldino - Cephalon - $14.5M
10. John Lechleiter - Eli Lilly - $13M
posted by TPR | 11:47 AM
1 Comments:
Prediction: Congress will be tut-tutting about Pharm Co. and Insurance Co. executive salaries in 6 months after they give themselves even more 'compensation', courtesy Obamacare.
Post a Comment
<< Home